Expression of S100A2 and Trefoil Factor Family Members in Epstein-Barr Virus Related Gastric Cancer

N

National University Health System (NUHS)

Status

Unknown

Conditions

Gastric Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT01100814
GA01/08/08

Details and patient eligibility

About

The investigators hypothesize that aberrant hypermethylation of tumour suppressor genes is an important mechanism for Epstein-Barr Virus (EBV) - related gastric carcinogenesis, the promoter hypermethylation status and the expression of S100A2 and TFF1 might be different between EBV-associated gastric cancer (GC) and non EBV-associated GC.

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Nil

Exclusion criteria

  • Nil

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems